EVIDENCE CPR Logo

Experience

The first CRO to conduct clinical trials to GCP standard in Russia, Ukraine, and Georgia, EVIDENCE was  also the first to conduct a multinational study in Russia. In addition, we participated in the large-scale multinational cardiovascular studies that achieved breakthrough results. These results were subsequently published in such international publications, as  JAMA, the Lancet, the New England Journal of Medicine and the European Heart Journal. The following areas were covered:

  • Acute Myocardial Infarction

  • Unstable Angina

  • Stable Angina

  • Peripheral Artery Occlusive Disease

  • Acute Peripheral Artery Thrombosis

  • Arterial Hypertension

  • Hiperlipidemia

  • Congestive Heart Failure

EVIDENCE currently manages over 350 active investigative sites; and over the years has recruited more than 28,000 patients. Our recruiting rates have been constantly highest among CRO participating in the same studies, with the highest quality of CRF completion. EVIDENCE and our clinical sites have received positive audit results from our study sponsors, as well as independent auditors, including the AAC Consulting Group (US), AAI/L.A.B. (Germany), BQA and CBA (UK).

EVIDENCE has  a proven track record in conducting  phase I-IV clinical studies in:

  • Allergology

  • Asthma

  • Dermatology

  • Diabetes Mellitus

  • Endocrinology

  • Gastroenterology

  • Gynecology

  • Hepatitis

  • Hematology

  • Infectious Diseases

  • Multiple Sclerosis

  • Nephrology

  • Neurology

  • Obstetrics

  • Oncology

  • Ophthalmology

  • Pulmonology

  • Rheumatoid Arthritis

  • Urology

Please click here to get the details.